The inhibition of the dopamine transporter (DAT) is a unique characteristic of lumateperone that sets it apart from other antipsychotic medications and may contribute to its enhanced effectiveness in treating schizophrenia [10]. This evidence concerns the gene SLC6A3 and schizophrenia.